Sorrento Therapeutics – 10X10Y

thumbnail
Reading Time: < 1 minute


Shares of Sorrento Therapeutics, a small pharma company based out of California, rose as much 344% intraday, on Friday after the company claimed that it has found an antibody that could potentially treat SARS-CoV-2, the virus that leads to COVID-19. While this is promising, the company still has to go through human trials and FDA approvals.

Let’s wait and watch.

Sorrento’s share volume traded on Friday was 72 times the average.

Source link | Twitter Handle

Every Wednesday and Saturday, we send Info-Graphic and FinMedium Weekly Digest newsletters to our 25000+ Subscribers.

Join Them Now!

Please Share :)
Moulik Jain
Moulik is 24, an Entrepreneur, and a successful Angel Investor at Beardo (exited). He is currently one of India's youngest Angel Investors.
Back To Top